Drawing for ZEAL HEALTH

USPTO serial 98432627

ZEAL HEALTH

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
SMITH, BRIDGETT G
Law office
TMO LAW OFFICE 115

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZEAL HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori P. Hager, Esq.

Lori P. Hager, Esq. Kyberia Legal, LLC88 South Finely Ave2rd Fl, Suite ABasking Ridge, NJ 07920

Goods and services

ClassDescriptionStatusFirst use
035Advertising agencies specializing in pharmaceutical branding, product launch and consulting; Advertising and marketing consultancy; Advertising and publicity services, namely, promoting the goods, services, brand identity and commercial information and news of third parties through digital technology, video, and live events; Advertising consultation; Advertising services in the field of pharmaceuticals; Advertising services, namely, creating corporate and brand identity for others; Advertising services, namely, promoting and marketing the goods and services of others in the field of pharmaceuticals via print and electronic media; Advertising, marketing and promotion services in the field of pharmaceuticals; Brand concept and brand development services for corporate clients; Business consultation in the field of pharmaceuticals; Concept and brand development in the pharmaceuticals; Concept and brand development services for corporate clients; Conducting market surveys; Digital advertising services; Market analysis and research services; Marketing consultation in the field of pharmaceuticals; Marketing consulting; Marketing plan development; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 21, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Sep 10, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 31, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 30, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 30, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Jan 30, 2025CNSLSUSPENSION LETTER WRITTEN—
Oct 30, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Oct 30, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jul 30, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2024DOCKASSIGNED TO EXAMINER—
Mar 4, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 4, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance